A prospective cohort study to evaluate the incidence of febrile neutropenia in patients receiving pegfilgrastim on-body injector versus other options for prophylaxis of febrile neutropenia: breast cancer subgroup analysis.

Reshma L MahtaniRajesh BelaniJeffrey CrawfordDavid DaleLucy DeCostaPrasad L GawadeChanh HuynhTatiana LawrenceSandra LewisWilliam W MacLaughlinMohit NarangRobert Rifkin

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2022)

gov , NCT02178475, registered 30 June, 2014.

Keyphrases

chemotherapy induced
urinary tract infection
risk factors
randomized controlled trial
open label
study protocol